Abstract

Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules

Author(s): McElhiney Linda F

Issue: Mar/Apr 2010 - Compounding for Men

Page(s): 118-123

Download in electronic PDF format for $75
  • Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules Page 1
  • Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules Page 2
  • Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules Page 3
  • Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules Page 4
  • Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules Page 5
  • Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules Page 6

Abstract

Published information on alternative ways to administer commercial dosage forms may not always be the best option for patients and the hospital staff. There are resources available to research information about drugs and excipients. A compounding pharmacist can review the information and, based on training and experience in compounding, develop a formulation to meet the individual needs of a patient. The tretinoin oral suspension formulation included with this article is an example of how to develop a formulation without a published stability study by utilizing various compounding references and databases.

Related Keywords

  • tretinoin
  • oral suspension
  • retinoid
  • retin A
  • category X
  • excipients
  • all-trans-retinoic acid
  • formulation

Related Categories

  • CANCER AND AIDS
  • DERMATOLOGY
  • EXCIPIENTS
  • FORMULATIONS
  • STABILITIES, COMPATIBILITIES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2010
Pg. 118-123
Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules
Author(s): McElhiney Linda F
Jul/Aug 2016
Pg. 327
Tretinoin 10-mg Oral Capsules
Author(s): Allen Loyd V Jr
Jan/Feb 2001
Pg. 65-67
Oral Liquid Vehicles, Featured Excipient:
Author(s): Allen Loyd V Jr
Jan/Feb 2004
Pg. 10-14
Women's Oral Health: Is There a Hormonal Link?
Author(s): Preckshot John
Jul/Aug 2008
Pg. 360
Tretinoin and (-)Alpha-Bisabolol Gel
Author(s): Allen Loyd V Jr
Jul/Aug 2008
Pg. 361
Tretinoin and Dexpanthenol Gel
Author(s): Allen Loyd V Jr
Jan/Feb 2001
Pg. 9-12
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Author(s): Schotik Debora
Jan/Feb 2001
Pg. 6-8
Pediatric Compounding: Coloring Outside the Lines
Author(s): Preckshot John
Jul/Aug 1999
Pg. 309-310
Acidifying Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Nov/Dec 2005
Pg. 456-461
Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions
Author(s): Fonseca Simonne C
Nov/Dec 2004
Pg. 458-460
A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid
Author(s): McElhiney Linda F
Mar/Apr 2002
Pg. 155-157
Stability of 4-Aminopyridine and 3,4-Diaminopyridine Oral Capsules
Author(s): Trissel Lawrence A, Xu Quanyun A, Zhang Yanping
Mar/Apr 2017
Pg. 105-108
Restructuring the Art of Health by Pharmacists: Formulation Designs with Oral Vehicles--Teaching Pharmacy Students
Author(s): Benischek Rita
Nov/Dec 2018
Pg. 516-526
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Sep/Oct 2023
Pg. 420
Nitazoxanide 20-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2017
Pg. 160-163
Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions
Author(s): Kabiche Djamila, Balde Issa-Bella, Majoul Elyes, Kabiche Sofiane, Bourguignon Elodie, Fontan Jean-Eudes, Cisternino Salvatore, Schlatter Joel
Jan/Feb 2016
Pg. 6-10
Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis
Author(s): Choo Winnie
Jan/Feb 2023
Pg. 58-59
Suspension Solution, Sugar Free
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 44
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 47
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr